Clinical Trial Update: A Pilot Study of KPL-914 in Recurrent Pericarditis [Phase 2]

View source ↗

Summary

Phase 2 pilot study of KPL-914 in recurrent pericarditis completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pericarditis

Drugs mentioned

• KPL-914 (KPL-914)

Snippet

Sponsor: Kiniksa Pharmaceuticals (UK), Ltd. | Conditions: Recurrent Pericarditis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-27